Royalty Pharma (RPRX)

NASDAQ: RPRX · Real-Time Price · USD

32.49

-0.33 (-1.01%)

At close: May 01, 2025, 3:59 PM

32.48

-0.05%

After-hours: May 01, 2025, 07:16 PM EDT

Royalty Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	1.33B	1.7B	230.06M	1.24B	1.7B	2.46B	1.52B	1.34B
Depreciation & Amortization	n/a	n/a	5.67M	23M	23.06M	23.92M	33.27M	33.27M
Stock-Based Compensation	2.34M	2.36M	2.17M	2.44M	5.43M	n/a	n/a	n/a
Other Working Capital	60.22M	667K	35.12M	17.41M	77.13M	-191.03M	-1.68B	-1.39B
Other Non-Cash Items	1.38B	1.28B	1.87B	767.22M	228.22M	-793.43M	1.63B	1.52B
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	53.38M	5.38M	32.66M	-16.32M	75.97M	-24.67M	-1.56B	-1.48B
Operating Cash Flow	2.77B	2.99B	2.14B	2.02B	2.03B	1.67B	1.62B	1.42B
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	-10.96M	-12.54M	-9.9M	-34.85M	-40.16M	-27.04M	-24.17M	-2M
Purchase of Investments	-2.74B	-2.12B	-2.57B	-3.59B	-3.94B	-2.75B	-422.4M	-2.3B
Sales Maturities Of Investments	118.36M	25.83M	1.55B	1.78B	1.2B	875.07M	750M	600M
Other Investing Acitivies	-49.32M	29.44M	n/a	-18.08M	15.08M	-250M	n/a	115M
Investing Cash Flow	-2.68B	-2.07B	-1.03B	-1.87B	-2.76B	-2.15B	303.42M	-1.59B
Debt Repayment	1.47B	-1B	n/a	1.27B	680.63M	-294M	-294M	907M
Common Stock Repurchased	-229.65M	-304.76M	n/a	n/a	n/a	-4.27M	n/a	n/a
Dividend Paid	-376.46M	-358.33M	-333.32M	-285.18M	-397.84M	-739.28M	-814.36M	-735.17M
Other Financial Acitivies	-503.97M	-485.67M	-611.53M	-602.24M	-704.36M	-154.08M	-270.74M	-295.08M
Financial Cash Flow	361.14M	-2.15B	-944.86M	385.11M	1.49B	-1.19B	-1.38B	-123.25M
Net Cash Flow	452.02M	-1.23B	169.7M	532.37M	762.48M	-1.68B	542.64M	-292.65M
Free Cash Flow	2.77B	2.99B	2.14B	2.02B	2.03B	1.67B	1.62B	1.42B